Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus

Clinical and Vaccine Immunology

Volumn 15, Issue 9, 2008, Pages 1489-1493

  Majetschak, Matthias ^a,b   Perez, Magdalena ^b   Sorell, Luis T ^b   Lam, Janet ^b   Maldonado, Marcos E ^b   Hoffman, Robert W ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; STATISTICS AS TOPIC;

EID: 51649096925     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00187-08     Document Type: Article

References (16)

1. Alarcon-Segovia, D., and M. H. Cardiel. 1989. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J. Rheumatol. 16:328-334.
2. Arribas, J., M. Luz Rodríguez, R. Alvarez-Do Forno, and J. G. Castaño. 1991. Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus. J. Exp. Med. 173:423-427.
3. Baumeister, W., J. Walz, F. Zühl, and E. Seemüller. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380.
4. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum. 35:630-640.
5. Egerer, K., U. Kuckelkorn, P. E. Rudolph, J. C. Rückert, T. Dörner, G. R. Burmester, P. M. Kloetzel, and E. Feist. 2002. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J. Rheumatol. 29:2045-2052.
6. Feist, E., T. Dörner, U. Kuckelkorn, G. Schmidtke, B. Micheel, F. Hiepe, G. R. Burmester, and P. M. Kloetzel. 1996. Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J. Exp. Med. 184:1313-1318.
7. Gladman, D., E. Ginzler, C. Goldsmith, P. Fortin, M. Liang, M. Urowitz, P. Bacon, S. Bombardieri, J. Hanly, E. Hay, D. Isenberg, J. Jones, K. Kalunian, P. Maddison, O. Nived, M. Petri, M. Richter, J. Sanchez-Guerrero, M. Snaith, G. Sturfelt, D. Symmons, and A. Zoma. 1996. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 39:363-369.
8. Goldberg, A. L., P. Cascio, T. Saric, and K. L. Rock. 2002. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol. Immunol. 39:147-164.
9. Greidinger, E. L., and R. W. Hoffman. 2001. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens. Arthritis Rheum. 44:368-375.
10. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system, Annu. Rev. Biochem. 67:425-479.
11. Majetschak, M., and L. T. Sorell. 2008. Immunological methods to quantify and characterize proteasome complexes: development and application. J. Immunol. Methods 334:91-103.
12. Patel, M. B., and M. Majetschak. 2007. Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues. Physiol. Res. 56:341-350.
13. Roth, A., B. Moser, C. Krenn, F. Roth-Walter, H. Hetz, S. Richter, M. Brunner, E. Jensen-Jarolim, E. Wolner, K. Hoetzenecker, G. Boltz-Nitulescu, and H. J. Ankersmit. 2005. Heightened levels of circulating 20S proteasome in critically ill patients. Eur. J. Clin. Investig. 35:399-403.
14. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271-1277.
15. Wada, M., M. Kosaka, S. Saito, T. Sano, K. Tanaka, and A. Ichihara. 1993. Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance. J. Lab. Clin. Med. 121:215-223.
16. Zoeger, A., M. Blau, K. Egerer, E. Feist, and B. Dahlmann. 2006. Circulating proteasomes are functional and have a subtype pattern distinct from 20S proteasomes in major blood cells. Clin. Chem. 52:2079-2086.